Abbott’s Simcor (niacin extended-release/simvastatin) Receives FDA Approval for New Dosage Strengths
ABBOTT PARK, Ill., July 28, 2010 /PRNewswire-FirstCall/ -- Abbott today received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of Simcor, a cholesterol medication. The new Simcor dosage strengths combine 40 mg...
Short URL: http://drugrehab.in/?p=70906
Posted by admin
on Jul 29 2010. Filed under New Drug Approvals.
You can follow any responses to this entry through the RSS 2.0.
Both comments and pings are currently closed.
